We previously reported the presence of serotonin (5-HT) in testes from golden hamster, a photoperiodic species which is a useful model for the study of states of male (in)fertility. The aims of this study were to investigate: (1) the presence of intrinsic sources of 5-HT in the testis; (2) the role of 5-HT in in vitro androgen production; (3) the serotoninergic receptor subtypes in the testis, and (4) the existence of interactions among the 5-HT receptors and the testicular catecholaminergic and corticotropin-releasing hormone (CRH) systems. Immunohistochemical studies revealed the presence of tryptophan hydroxylase, a 5-HT-biosynthetic enzyme, in interstitial cells which show the characteristic punctate chromatin pattern of Leydig cells. We describe an inhibitory action of 5-HT on testosterone, dihydrotestosterone, and androstane-3α,17β-diol production from testes of peripubertal and adult hamsters maintained in a long photoperiod (14/10 h light/dark), and adult animals exposed to a short photoperiod (6/18 h light/dark). By using several agonists and antagonists of 5-HT receptors, we characterized 5-HT1A and 5-HT2A receptor subtypes involved in the inhibitory action of this neurotransmitter on human chorionic gonadotropin stimulated cyclic adenosine monophosphate and testosterone production. CRH also produced a negative modulation of both parameters, but epinephrine and norepinephrine, through α1/β1-adrenergic receptors, exerted a stimulatory action. 5-HT1A, 5-HT2, and CRH antagonists showed that the testicular activity of the serotoninergic system, but also the α1/β1-adrenergic receptor system, is mediated by CRH. Moreover, interactions between the 5-HT2A receptor system and α1/β-adrenergic receptors have been established. Thus, these data suggest that α1/β1-adrenergic receptors are involved in the local regulatory action exerted by 5-HT on steroidogenesis through a 5-HT2-receptor-mediated response and the CRH system.

Keywords:
Gonadal steroids, Testis, Hamster, Serotonin, Catecholamines, Steroidogenesis, Corticotropin-releasing hormone, Serotonin agonists, Serotonin antagonists, Immunocytochemistry
1.
Ritta MN, Campos MB, Calandra RS: Effects of GABA and benzodiazepines on testicular androgen production. Life Sci 1987;40:791–798.
2.
Campos MB, Vitale ML, Ritta MN, Chiocchio SR, Calandra RS: Catecholamine distribution in adult rat testis. Andrologia 1990;22:247–252.
3.
Campos MB, Vitale ML, Calandra RS, Chiocchio SR: Serotonergic innervation of the rat testis. J Reprod Fertil 1990;88:475–479.
4.
Zhu BC, Chiocchio SR, Suburo AM, Tramezzani JH: Monoaminergic and peptidergic contributions of the superior and inferior spermatic nerves to the innervation of the testis in the rat. J Androl 1995;16:248–258.
5.
Mayerhofer A: Leydig cell regulation by catecholamines and neuroendocrine messengers; in Payne AH, Hardy MP, Russell LD (eds): The Leydig Cell. Vienna, Cache River Press, 1996, pp 407–417.
6.
Frungieri MB, Gonzalez-Calvar SI, Chandrashekar V, Rao JN, Bartke A, Calandra RS: Testicular gamma-aminobutyric acid and circulating androgens in Syrian and Djungarian hamsters during sexual development. Int J Androl 1996;19:164–170.
7.
Frungieri MB, Gonzalez-Calvar SI, Calandra RS: Influence of photoinhibition on GABA and glutamic acid levels, and on glutamate decarboxylase activity in the testis and epididymis of the golden hamster. Int J Androl 1996;19:171–178.
8.
Frungieri MB, Gonzalez-Calvar SI, Rubio M. Ozu M, Lustig L, Calandra RS: Serotonin in golden hamster testes: Testicular levels, immunolocalization and role during sexual development and photoperiodic regression-recrudescence transition. Neuroendocrinology 1999;69:299–308.
9.
Frungieri MB, Urbanski HF, Höhne-Zell B, Mayerhofer A: Neuronal elements in the testis of the rhesus monkey: Ontogeny, characterization and relationship to testicular cells. Neuroendocrinology 2000;71:43–50.
10.
Mayerhofer A, Frungieri MB, Fritz S, Bulling A, Jessberger B, Vogt HJ: Evidence for catecholaminergic, neuronlike cells in the adult human testis: Changes associated with testicular pathologies. J Androl 1999;20:341–347.
11.
Bartke A: Male hamster reproductive endocrinology; in Siegel HI (ed): The Hamster. New York, Plenum Press, 1985, pp 73–98.
12.
Dufau ML, Tinajero JC, Fabbri A: Corticotropin-releasing factor: An antireproductive hormone of the testis. FASEB J 1993;7:299–307.
13.
Eison AS, Yocca FD, Gianutsos G: Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: Modulatory role of beta-adrenergic receptors. J Pharmacol Exp Ther 1988;246:571–577.
14.
Eison AS, Freeman RP, Guss VB, Mullins L, Wright RN: Melatonin agonists modulate 5-HT2A receptor-mediated neurotransmission: Behavioral and biochemical studies in the rat. J Pharmacol Exp Ther 1995;273:304–308.
15.
Eison AS, Mullins UL: Regulation of central 5-HT2A receptors: A review of in vivo studies. Behav Brain Res 1996;73:177–181.
16.
Wang SJ, Cheng LL, Gean PW: Cross-modulation of synaptic plasticity by β-adrenergic and 5-HT1A receptors in the rat basolateral amygdala. J Neurosci 1999;19:570–577.
17.
Hensler JG, Cervera LS, Miller HA, Corbitt J: Expression and modulation of 5-hydroxytryptamine1A receptors in P11 cells. J Pharmacol Exp Ther 1996;278:1138–1145.
18.
Frungieri MB, Gonzalez-Calvar SI, Calandra RS: Polyamine levels in testes and seminal vesicles from adult golden hamsters during gonadal regression-recrudescence. J Androl 1996;17:683–691.
19.
Hedger MP, Eddy EM: Monoclonal antibodies against rat Leydig cell surface antigens. Biol Reprod 1986;35:1309–1319.
20.
Levy H, Deane HW, Rubin BL: Visualization of steroid 3β-ol-dehydrogenase activity in tissues of intact and hypophysectomized rats. Endocrinology 1959;65:932–943.
21.
Mayerhofer A, Bartke A, Steger RW: Catecholamine effects on testicular testosterone production in the gonadally active and the gonadally regressed adult golden hamster. Biol Reprod 1989;40:752–761.
22.
Frungieri MB, Gonzalez-Calvar SI, Bartke A, Calandra RS: Influence of age and photoperiod on steroidogenic function of the testis in the golden hamster. Int J Androl 1999;22:243–252.
23.
Suescun MO, Gonzalez SI, Chiauzzi VA, Calandra RS: Effects of induced hypoprolactinemia on testicular function during gonadal maturation in the rat. J Androl 1985;6:77–82.
24.
Del Punta K, Charreau EH, Pignataro OP: Nitric oxide inhibits Leydig cell steroidogenesis. Endocrinology 1996;137:5337–5343.
25.
Birnbaumer L: Techniques in cyclic nucleotide research; in Schrader WT, O’Malley BW (eds): Laboratory Methods Manual for Hormone Action and Molecular Endocrinology, ed 4. Houston, Baylor College of Medicine, 1980, ch 9, sect 2 (V), pp 9–16.
26.
Brooker G, Harper JF, Terasaki WL, Moylan RD: Radioimmunoassay of cyclic AMP and cyclic GMP; in Brooker G, Greengard P (eds): Advances in Cyclic Nucleotide Research. New York, Raven Press, 1979, vol 10, pp 1–32.
27.
Tinajero JC, Fabbri A, Dufau ML: Regulation of corticotropin-releasing factor secretion from Leydig cells by serotonin. Endocrinology 1992;130:1780–1788.
28.
Humphrey PAP: The characterization and classification of neurotransmitter receptors. Ann NY Acad Sci 1997;812:1–13.
29.
Mayerhofer A, Calandra RS, Bartke A: Cyclic adenosine monophosphate (cAMP) does not mediate the stimulatory action of norepinephrine on testosterone production in the testis of the golden hamster. Life Sci 1991;48:1109–1114.
30.
Mayerhofer A, Steger RW, Gow G, Bartke A: Catecholamines stimulate testicular testosterone release of the immature golden hamster via interaction with alpha- and beta-adrenergic receptors. Acta Endocrinol (Copenh) 1992;127:526–530.
31.
Yocca FD, Wright RN, Margraf RR, Eison AS: 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats. Pharmacol Biochem Behav 1990;35:252–254.
32.
Yocca FD, Eison AS, Hyslop DK, Ryan E, Taylor DP, Gianutsos G: Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment. Life Sci 1991;49:1777–1785.
33.
Araneda R, Andrade R: 5-Hydroxytryptamine-2 and 5-hydroxytryptamine-1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 1991;40:399–412.
34.
Eison AS, Yocca FD, Gianutsos G: Effect of chronic administration of antidepressant drugs on 5-HT2-mediated behavior in the rat following noradrenergic or serotonergic denervation. J Neural Transm Gen Sect 1991;84:19–32.
35.
Dow RC, Williams BC, Bennie J, Carroll S, Fink G: A central 5-HT2 receptor mechanism plays a key role in the proestrous surge of luteinizing hormone in the rat. Psychoneuroendocrinology 1994;19:395–399.
36.
Holmes MC, Di Rienzo G, Beckford U, Gillham B, Jones MT: Role of serotonin in the control of secretion of corticotropin releasing factor. J Endocrinol 1982;93:151–160.
37.
Ulisse S, Fabbri A, Dufau ML: Corticotropin-releasing factor receptors and actions in rat Leydig cells. J Biol Chem 1989;264:2156–2163.
38.
Ellis LC: Inhibition of rat testicular androgen synthesis in vitro by melatonin and serotonin. Endocrinology 1972;90:17–28.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.